IRIDEX CORP

IRIX ·Healthcare, Medical Devices, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2026 FY2024 FY2023 FY2022 FY2021 FY2019 FY2018 FY2017
Assets
Cash & Equivalents $6.0M $2.4M $7.0M $13.9M $11.6M $12.7M $21.2M $21.7M
Accounts Receivable $7.6M $6.0M $6.7M $6.2M $7.3M $9.3M $9.1M $7.9M
Inventory $7.9M $10.8M $9.9M $10.6M $5.7M $8.2M $8.8M $9.4M
Total Current Assets $25.3M $23.6M $27.5M $35.8M $25.4M $30.6M $39.6M $39.5M
Property, Plant & Equipment $58.0K $115.0K $351.0K $462.0K $449.0K $730.0K $1.2M $1.4M
Goodwill $965.0K $965.0K $965.0K $965.0K $400.0K $533.0K $533.0K $533.0K
Intangible Assets (Excl. Goodwill) $984.0K $1.3M $1.6M $2.0M $68.0K $84.0K $100.0K $116.0K
Total Assets $29.2M $29.1M $34.4M $42.3M $28.0M $34.8M $41.7M $41.6M
Liabilities
Accounts Payable $5.4M $7.0M $4.5M $3.9M $1.1M $2.6M $2.5M $1.7M
Total Current Liabilities $13.2M $16.6M $13.0M $12.5M $8.7M $9.8M $10.5M $10.4M
Long-Term Debt $1.0M $1.2M
Total Liabilities $24.2M $27.0M $24.9M $25.1M $10.6M $12.1M $11.7M $11.1M
Stockholders' Equity
Retained Earnings $-92.4M $-88.0M $-79.0M $-69.7M $-56.9M $-50.6M $-41.8M $-29.0M
Total Stockholders' Equity $4.9M $2.1M $9.5M $17.2M $17.4M $22.7M $30.0M $30.5M
← Newer Page 1 of 2 Older →